Related references
Note: Only part of the references are listed.Therapeutic drug monitoring of imipenem and the incidence of toxicity and failure in hospitalized patients: a retrospective cohort study
A. Bricheux et al.
CLINICAL MICROBIOLOGY AND INFECTION (2019)
Optimization of the treatment with beta-lactam antibiotics in critically ill patientsguidelines from the French Society of Pharmacology and Therapeutics (Societe Francaise de Pharmacologie et TherapeutiqueSFPT) and the French Society of Anaesthesia and Intensive Care Medicine (Societe Francaise d'Anesthesie et ReanimationSFAR)
Romain Guilhaumou et al.
CRITICAL CARE (2019)
Therapeutic Drug Monitoring of Beta-Lactams and Other Antibiotics in the Intensive Care Unit: Which Agents, Which Patients and Which Infections?
Anouk E. Muller et al.
DRUGS (2018)
Cefepime plasma concentrations and clinical toxicity: a retrospective cohort study
T. Huwyler et al.
CLINICAL MICROBIOLOGY AND INFECTION (2017)
The ANTIBIOPERF study: a nationwide cross-sectional survey about practices for β-lactam administration and therapeutic drug monitoring among critically ill patients in France
A. Charmillon et al.
CLINICAL MICROBIOLOGY AND INFECTION (2016)
Piperacillin concentration in relation to therapeutic range in critically ill patients - a prospective observational study
Johannes Zander et al.
CRITICAL CARE (2016)
Augmented renal clearance, low β-lactam concentrations and clinical outcomes in the critically ill: An observational prospective cohort study
Angela Huttner et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2015)
An international, multicentre survey of -lactam antibiotic therapeutic drug monitoring practice in intensive care units
Gloria Wong et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Genomic Load from Sputum Samples and Nasopharyngeal Swabs for Diagnosis of Pneumococcal Pneumonia in HIV-Infected Adults
Werner C. Albrich et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2014)
Is the standard dose of amoxicillin-clavulanic acid sufficient?
Michiel Haeseker et al.
BMC PHARMACOLOGY & TOXICOLOGY (2014)
Optimal exposures of ceftazidime predict the probability of microbiological and clinical outcome in the treatment of nosocomial pneumonia
Anouk E. Muller et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Does Beta-lactam Pharmacokinetic Variability in Critically Ill Patients Justify Therapeutic Drug Monitoring? A Systematic Review
Fekade Bruck Sime et al.
ANNALS OF INTENSIVE CARE (2012)
Association between Drug and Vaccine Use and Acute Immune Thrombocytopenia in Childhood A Case-Control Study in Italy
Federica Bertuola et al.
DRUG SAFETY (2010)
Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections
Peggy S. McKinnon et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2008)
Share Paper
